Meril has got ICMR approval for its self-use rapid antigen test for Covid-19, CoviFind. The test delivers results in 15 minutes, Meril said in a statement.
Medtech firm Meril has said it has received approval from the Indian Council of Medical Research (ICMR) for its self-use rapid antigen test kit for Covid-19.
Meril’s indigenous home-use rapid antigen test kits “CoviFind” will expand access to Covid-19 testing, while also helping the nation meet the demand for increased and frequent screening to curb the spread of the pandemic, Meril said in a statement.
The test delivers results swiftly, providing accurate results in 15 minutes, it added.
“By making reliable rapid antigen testing available to all through a convenient format, Meril''s CoviFind test will facilitate early detection, isolation, treatment and contact tracing," Meril Senior Vice-President (Corporate Strategy) Sanjeev Bhatt said.
Meril said it has supplied a large number of tests across its Covid-19 diagnostics offerings across India, which include a multiplex RT-PCR test, Kavach antibody tests in partnership with ICMR.
What will the test include?
The test kit is equipped with testing materials including a test device, one sterile nasal swab and a pre-filled buffer tube with a cap and is priced at Rs 250 as an affordable single-pack, the company said.
